GADD34-deficient mice develop obesity, nonalcoholic fatty liver disease, hepatic carcinoma and insulin resistance

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Nishio, Naomi ^a   Isobe, Ken Ichi ^a,b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA WOMEN'S UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PALMITIC ACID; PHOSPHOPROTEIN PHOSPHATASE 1; PPP1R15A PROTEIN, MOUSE; STRESS ACTIVATED PROTEIN KINASE;

ADIPOGENESIS; AGING; ANIMAL; BODY WEIGHT; CHO CELL LINE; COMPLICATION; CRICETULUS; DEFICIENCY; DRUG EFFECTS; FATTY LIVER; HAMSTER; INSULIN RESISTANCE; LIPID DIET; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MOUSE; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADIPOGENESIS; AGING; ANIMALS; BODY WEIGHT; CARCINOMA, HEPATOCELLULAR; CHO CELLS; CRICETINAE; CRICETULUS; DIET, HIGH-FAT; FATTY LIVER; INSULIN; INSULIN RESISTANCE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; LIVER NEOPLASMS; MALE; MICE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PALMITIC ACID; PHOSPHORYLATION; PROTEIN PHOSPHATASE 1; SIGNAL TRANSDUCTION;

EID: 84940473681     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13519     Document Type: Article

References (50)

1. Tiniakos, D. G., Vos, M. B. & Brunt, E. M. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 5, 145-171 (2010).
2. Angulo, P., Keach, J. C., Batts, K. P. & Lindor, K. D. Independent predictors of liver fbrosis in patients with nonalcoholic steatohepatitis. Hepatology 30, 1356-1362 (1999).
3. Guerrero, R., Vega, G. L., Grundy, S. M. & Browning, J. D. Ethnic diferences in hepatic steatosis: an insulin resistance paradox? Hepatology 49, 791-801 (2009).
4. Weston, S. R. et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 41, 372-379 (2005).
5. Cornier, M. A. et al. The metabolic syndrome. Endocr Rev 29, 777-822 (2008).
6. McCullough, A. J. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 8, 521-533, viii (2004).
7. Fornace, A. J., Alamo, I. & Hollander, M. C. DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci USA 85, 8800-8804 (1988).
8. Novoa, I., Zeng, H., Harding, H. P. & Ron, D. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J Cell Biol 153, 1011-1022 (2001).
9. Jousse, C. et al. Inhibition of a constitutive translation initiation factor 2alpha phosphatase, CReP, promotes survival of stressed cells. J Cell Biol 163, 767-775 (2003).
10. Connor, J. H., Weiser, D. C., Li, S., Hallenbeck, J. M. & Shenolikar, S. Growth arrest and DNA damage-inducible protein GADD34 assembles a novel signaling complex containing protein phosphatase 1 and inhibitor 1. Mol Cell Biol 21, 6841-6850 (2001).
11. Brush, M. H., Weiser, D. C. & Shenolikar, S. Growth arrest and DNA damage-inducible protein GADD34 targets protein phosphatase 1 alpha to the endoplasmic reticulum and promotes dephosphorylation of the alpha subunit of eukaryotic translation initiation factor 2. Mol Cell Biol 23, 1292-1303 (2003).
12. Novoa, I. et al. Stress-induced gene expression requires programmed recovery from translational repression. EMBO J 22, 1180-1187 (2003).
13. Kojima, E. et al. The function of GADD34 is a recovery from a shutof of protein synthesis induced by ER stress: elucidation by GADD34-defcient mice. FASEB J 17, 1573-1575 (2003).
14. Li, H. Y. et al. Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1. Nat Immunol 9, 533-541 (2008).
15. Watanabe, R. et al. GADD34 inhibits mammalian target of rapamycin signaling via tuberous sclerosis complex and controls cell survival under bioenergetic stress. Int J Mol Med 19, 475-483 (2007).
16. Uddin, M. N., Ito, S., Nishio, N., Suganya, T. & Isobe, K. Gadd34 induces autophagy through the suppression of the mTOR pathway during starvation. Biochem Biophys Res Commun 407, 692-698 (2011).
17. Grishin, A. V., Azhipa, O., Semenov, I. & Corey, S. J. Interaction between growth arrest-DNA damage protein 34 and Src kinase Lynnegatively regulates genotoxic apoptosis. Proc Natl Acad Sci USA 98, 10172-10177 (2001).
18. Nishio, N., Ito, S. & Isobe, K. Loss of GADD34 induces early age-dependent deviation to the myeloid lineage. Immunol Cell Biol 92, 170-180 (2014).
19. Muoio, D. M. & Newgard, C. B. Obesity-related derangements in metabolic regulation. Annu Rev Biochem 75, 367-401 (2006).
20. Samuel, V. T. & Shulman, G. I. Mechanisms for insulin resistance: common threads and missing links. Cell 148, 852-871 (2012).
21. Majka, S. M., Barak, Y. & Klemm, D. J. Concise review: adipocyte origins: weighing the possibilities. Stem Cells 29, 1034-1040 (2011).
22. Geofrey, C., Farrell, J. G., Pauline de la, M. H. & Arthur, J. McCullough. Fatty Liver Disease: NASH and Related Disorders. Blackwell book. (2005).
23. Bataller, R. & Brenner, D. A. Liver fbrosis. J Clin Invest 115, 209-218 (2005).
24. Wynn, T. A. & Ramalingam, T. R. Mechanisms of fbrosis: therapeutic translation for fbrotic disease. Nat Med 18, 1028-1040 (2012).
25. Rosen, E. D. et al. C/EBPalpha induces adipogenesis through PPARgamma: a unifed pathway. Genes Dev 16, 22-26 (2002).
26. Tontonoz, P. & Spiegelman, B. M. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 77, 289-312 (2008).
27. Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796-1808 (2003).
28. Xu, H. et al. Chronic infammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112, 1821-1830 (2003).
29. Louet, J. F. et al. Oncogenic steroid receptor coactivator-3 is a key regulator of the white adipogenic program. Proc Natl Acad Sci USA 103, 17868-17873 (2006).
30. Ichimura, A. et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 483, 350-354 (2012).
31. Girard, J., Perdereau, D., Foufelle, F., Prip-Buus, C. & Ferré, P. Regulation of lipogenic enzyme gene expression by nutrients and hormones. FASEB J 8, 36-42 (1994).
32. Smith, P. J., Wise, L. S., Berkowitz, R., Wan, C. & Rubin, C. S. Insulin-like growth factor-I is an essential regulator of the diferentiation of 3T3-L1 adipocytes. J Biol Chem 263, 9402-9408 (1988).
33. Shi, H. et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116, 3015-3025 (2006).
34. Aguirre, V. et al. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 277, 1531-1537 (2002).
35. Oyadomari, S., Harding, H. P., Zhang, Y., Oyadomari, M. & Ron, D. Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice. Cell Metab 7, 520-532 (2008).
36. Gadd, V. L. et al. The portal infammatory infltrate and ductular reaction in human nonalcoholic fatty liver disease. Hepatology 59(4), 1393-1405 (2014).
37. Uysal, K. T., Wiesbrock, S. M., Marino, M. W. & Hotamisligil, G. S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389, 610-614 (1997).
38. Kanda, H. et al. MCP-1 contributes to macrophage infltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116, 1494-1505 (2006).
39. Oliver, E., McGillicuddy, F., Phillips, C., Toomey, S. & Roche, H. M. The role of infammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic efects of long-chain n-3 PUFA. Proc Nutr Soc 69, 232-243 (2010).
40. Schenk, S., Saberi, M. & Olefsky, J. M. Insulin sensitivity: modulation by nutrients and infammation. J Clin Invest 118, 2992-3002 (2008).
41. Gao, Z. et al. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem 277, 48115-48121 (2002).
42. Hirosumi, J. et al. A central role for JNK in obesity and insulin resistance. Nature 420, 333-336 (2002).
43. Lee, D. F. et al. IKK beta suppression of TSC1 links infammation and tumor angiogenesis via the mTOR pathway. Cell 130, 440-455 (2007).
44. Ozes, O. N. et al. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc Natl Acad Sci USA 98, 4640-4645 (2001).
45. Gao, Z., Zuberi, A., Quon, M. J., Dong, Z. & Ye, J. Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases. J Biol Chem 278, 24944-24950 (2003).
46. Wen, H. et al. Fatty acid-induced NLRP3-ASC infammasome activation interferes with insulin signaling. Nat Immunol 12, 408-415 (2011).
47. Osborn, O. & Olefsky, J. M. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 18, 363-374 (2012).
48. Karlmark, K. R. et al. Hepatic recruitment of the infammatory Gr1+ monocyte subset upon liver injury promotes hepatic fbrosis. Hepatology 50, 261-274 (2009).
49. Pellicoro, A., Ramachandran, P., Iredale, J. P. & Fallowfeld, J. A. Liver fbrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol 14, 181-194 (2014).
50. Zhang P. Analysis of Mouse Liver Glycogen Content. Bio-protocol 2(10), e186 (2012).